Host Resistance and Immune Responses in Advanced Age

Clinics in Geriatric Medicine

Volumn 23, Issue 3, 2007, Pages 463-479

  Castle, Steven C ^a   Uyemura, Koichi ^a   Fulop, Tamas ^b   Makinodan, Takashi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD28 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PROTEIN P42; PROTEIN P44; TOLL LIKE RECEPTOR 4;

AGING; B LYMPHOCYTE ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOSENESCENCE; INFECTION RISK; MEDIATOR RELEASE; REVIEW; SENESCENCE; T LYMPHOCYTE ACTIVATION; TH1 CELL; VACCINATION;

AGED; AGED, 80 AND OVER; AGING; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; RISK FACTORS;

EID: 34447286677     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2007.03.005     Document Type: Review

References (70)

1. Stevenson K.B. Regional data set of infection rates for long-term care facilities: description of a valuable benchmarking tool. Am J Infect Control 27 (1999) 20-26
2. Castle S., Uemura K., Rafi A., et al. Reduced immunity of elders with chronic illness correlates with cumulative illness rating scale, but not age. J Am Geriatr Soc 53 (2005) 1565-1569
3. Candore G., Aquino A., Balistreri C.R., et al. Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann N Y Acad Sci 1067 (2006) 282-287
4. Loeb M., McGeer A., McArthur M., et al. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 159 (1999) 2058-2064
5. High K.P., Trader M., Pahor M., et al. Intraindividual variability and the effect of acute illness on immune senescence markers. J Am Geriatr Soc 53 (2005) 1761-1766
6. Lemaitre B., Nicolas E., Michaut L., et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 6 (1996) 973-983
7. Fulop T., Larbi A., Wikby A., et al. Dysregulation of T cell function in the elderly: Scientific basis and clinical implications. Drugs Aging 22 (2005) 589-603
8. Pawelec G. Immunosenescence: impact in the young as well as the old?. Mech Ageing Dev 108 (1999) 1-7
9. Wick G., and Grubeck-Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 32 (1997) 401-413
10. Burns E.A., and Goodwin J.S. Immunodeficiency of aging. Drugs Aging 11 (1997) 374-397
11. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
12. Sudeghi H.M., Schnelle J.F., Thoma J.K., et al. Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol 34 (1999) 959-965
13. Orme I. Mechanisms underlying the increased susceptibility of aged mice to tuberculosis. Nutr Rev 53 S4 (1995) S35-S40
14. Larbi A., Douziech N., Fortin C., et al. The role of MAPK pathway alterations in GM-CSF-modulated human neutrophil apoptosis with aging. Immun Ageing 2 1 (2005) 6
15. Lord J.M., Butcher S., Killampali V., et al. Neutrophil ageing and immunosenescence. Mech Ageing Dev 122 (2001) 1521-1535
16. Agrawal A., Agrawal S., and Gupta S. Dendritic cells in human aging. Exp Gerontol (2006)
17. Fulop T., Larbi A., Douziech N., et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 3 (2004) 217-226
18. Fortin C.F., Larbi A., Lesur O., et al. Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J Leukoc Biol 79 (2006) 1061-1072
19. Steger M.M., Maczek C., and Grubeck-Loebenstein B. Morphologically intact dendritic cells can be derived from peripheral blood of aged individuals. Clin Exp Immunol 105 (1996) 544-550
20. Ponnapan U., Zhong M., and Trebilcock G.U. Decreased proteosome-mediated degradation in T cells from the elderly: a role in immune senescence. Cell Immunol 192 (1999) 167-174
21. Steger M.M., Maczek C., and Grubeck-Loebenstein B. Peripheral blood dendritic cells reinduce proliferation in in vitro aged T cell populations. Mech Ageing Dev 93 (1997) 125-130
22. Murasko D.M., Bernstein E.D., Gardner E.M., et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 37 (2002) 427-439
23. Castle S., Uyemura K., Crawford W.W., et al. Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12. Exp Gerontol 34 (1999) 243-252
24. Grolleau-Julius A., Garg M.R., Mo R.R., et al. Effect of aging on bone marrow-derived murine CD11c+CD4-CD8- dendritic cell function. J Gerontol A Biol Sci Med Sci 61 10 (2006) 1039-1047
25. Thoma-Usynski S., Kiertscher S.M., Ochoa M.T., et al. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol 165 (2000) 3804-3810
26. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
27. Lebre M.C., Antons J.C., Kalinski P., et al. Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a Type-1 polarizing phenotype in dendritic cells: roll of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin-18. J Invest Dermatol 120 6 (2003) 990-997
28. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440 (2006) 808-812
29. van Duin D., Mohanty S., Thomas V., et al. Age-associated defect in human TLR-1/2 function. J Immunol 178 (2007) 970-975
30. Effros R.B. Replicative senescence of CD8 T cells: effect of human aging. Exp Gerontol 39 (2004) 517-524
31. In: Hodes R.J., and Fauci A.S. (Eds). Report of task force on immunology and aging. National Institutes of Aging and Allergy and Infectious Disease (1996), US Department of Health and Human Services, Bethesda (MD)
32. Gregg R.K., Jain R., Schoenleber S.J., et al. A sudden decline in active membrane-bound TGF-beta impairs T regulatory function and protection against diabetes. J Immunol 173 (2004) 7308-7316
33. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
34. Simons K., and Ikonen E. How cells handle cholesterol. Science 290 (2000) 1721-1726
35. He H.T., Lellouch A., and Marguet D. Lipid rafts and the initiation of T cell signaling. Semin Immunol 17 (2005) 23-33
36. Schindowski K., Frohlich L., Maurer L., et al. Age-related impairment of human T lymphocytes' activation: specific differences between CD4(+) and CD8(+) subsets. Mech Ageing Dev 123 (2002) 375-390
37. Ponnapan U., Trebilcock G.U., and Zheng M.Z. Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NfkappaB activation in T lymphocytes during aging: evidence for altered IkappaB-alpha phosphorylation and degradation. Exp Gerontol 34 (1999) 95-107
38. Hermiston M.L., Xu Z., Majeti R., et al. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin Invest 109 (2002) 9-14
39. Gupta S. Molecular and biochemical pathways of apoptosis in lymphocytes and aged humans. Vaccine 18 (2000) 1596-1601
40. Werner A.B., de Vries E., Tait S.W., et al. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and BAX but differentially regulate events downstream from truncated Bid. J Biol Chem 277 (2002) 40760-40770
41. Fas S.C., Fritzshing B., Suri-Payer E., et al. Death receptor signaling and its function in the immune system. Curr Dir Autoimmun 9 (2006) 1-17
42. Kirchoff S., Muller W.W., Li-Webber M., et al. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated T cell. Eur J Immunol 30 (2000) 2765-2774
43. Gupta S., Kim C., Yel L., et al. A role of fas-associated death domain (FADD) in increased apoptosis in aged humans. Clin Immunol 242 (2004) 4-9
44. Larbi A., Douzeich N., Fortin C., et al. Differential role of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes with aging. Cell Signal 18 (2006) 1017-1030
45. Goronzy J.J., Fulbright J.W., Crowson C.S., et al. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75 (2001) 12182-12187
46. Wikby A., Ferguson F., Forsey R., et al. An immune risk phenotype, congnitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenerian humans. J Gerontol A Biol Sci Med Sci 60 (2005) 556-565
47. Ferrucci L., Cavazzini C., Corsi A., et al. Biomarkers of frailty in older persons. J Endocrinol Invest 25 (2002) 10-15
48. Park H.S., Park J.Y., and Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha, and IL-6. Diabetes Res Clin Pract 69 (2005) 29-35
49. Daily R.W., Eun S.Y., Russell C.E., et al. B cells of aged mice show decreased expansion in response to antigen, but are normal in effector function. Cell Immunol 214 (2001) 99-109
50. Johnson S.A., and Cambier J.C. Ageing, autoimmunity, and arthritis: senescence of the B cell compartment-implications for humoral immunity. Arthritis Res 6 (2004) 131-139
51. Agematsu K., Hokibara S., Nagumo H., et al. CD27: a memory B-cell marker. Immunol Today 21 (2000) 204-206
52. Gupta S., Su H., Bi R., et al. Life and death of lymphocytes: a role in immunosenescence. Immun Ageing 23 (2005) 2-12
53. Montes C.L., Maletto B.A., Acosta Rodriquez E.V., et al. B cells from aged mice exhibit reduced apoptosis upon B-cell antigen receptor stimulation and differential ability to up-regulate survival signals. Clin Exp Immunol 143 (2006) 30-40
54. Potter J.M., O'Donnel B., Carman W.F., et al. Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long term care. Age Ageing 28 (1999) 141-145
55. Trzonkowski P., Mysliwska J., Szmit E., et al. Association between cytomegalovirus infection, enhanced proinflammatory resonse and low level of anti-hemagglutins during the anti-influenza vaccination: an impact of immunosenescence. Vaccine 21 25-26 (2003) 3826-3836
56. Fraser G.M., Ochana N., Fenyves D., et al. Increasing serum creatinine and age reduce the response to hepatitis B vaccine in renal failure patients. J Hepatol 21 (1994) 450-454
57. Ligthart G.J., Corberand J.X., Fournier C., et al. Admission criteria for immunogerontological studies in man: the SENIEUR Protocol. Mech Ageing Dev 28 (1984) 47-55
58. Price GB, Makinodan T. Immunologic deficiencies in senescence II. Characterization of extrinsic deficiencies. J Immunol 1972;108:41-7.
59. Sehl M.E., and Yates F.E. Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci 56 (2001) B198-B208
60. Reuben D.B., Cheh A.I., Harris T.B., et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 50 4 (2002) 638-644
61. Elousa R., Bartali B., Ordovas J.M., et al. Association between physical activity, physical performance and inflammatory biomarkers in an elderly population: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 60 (2005) 760-767
62. Bruunsgaard H., and Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 23 (2003) 15-39
63. Xial H., Siddiqui J., and Remick D.G. Mechanisms of mortality in early and late sepsis. Infect Immun 74 9 (2006) 5227-5235
64. Mysliwska J., Bryl E., Foerster J., et al. The upregulation of TNFa production is not a generalised phenomenon in the elderly between their sixth and seventh decades of life. Mech Ageing Dev 107 (1999) 1-14
65. Fernandez-Serrano S., Dorca J., Coromines M., et al. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 10 (2003) 813-820
66. Glynn P., Coakley R., Kilgallen I., et al. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 54 (1999) 51-55
67. Gallagher P.M., Lowe G., Fitzgerald T., et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 58 (2003) 154-156
68. Ribeiro-Rodrigues R., Co T.R., Johnson J.L., et al. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of Mycobacterial clearance. Clin Diagn Lab Immunol 9 (2002) 818-823
69. Monton C., Ewig S., Torres A., et al. Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J 14 1 (1999) 218-220
70. Ikonomidis I., Andreotti F., Economou E., et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100 8 (1999) 793-798